Nomogram for Predicting Recurrence-Free Survival in Chinese Women with Endometrial Cancer after Initial Therapy: External Validation

Figure 2

Nomograms for predicting 3- and 5-year recurrence-free survival (RFS) in patients with endometrial cancer. In order to evaluate the recurrence-free survival rate of each patient, the score of each variable was calculated by the value of the “Points” axis, and the sum of the values of all variables was corresponding to the number of the “Total points” axis. The vertical line of the total score was corresponding to 3- and 5-year probability of recurrence-free survival.